FiberChoice recall
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline announces March 20 it is recalling 144,000 bottles of FiberChoice Plus Multivitamins because fish gelatin, a known allergen, was not declared on the label. The recall affects 90-count, 16 oz. bottles that began shipping to retailers Jan. 15. No reports of adverse reactions had been reported as of the recall announcement. The Food Allergen Labeling Consumer Protection Act of 2004 requires that manufacturers of dietary supplements disclose major food allergens on product labeling (1"The Tan Sheet" Oct. 24, 2005, p. 10). GSK completed its acquisition of FiberChoice manufacturer CNS in December 2006 (2"The Tan Sheet" Jan. 1, 2007, In Brief)...
You may also be interested in...
FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens
Manufacturers of dietary supplements are required to begin labeling products that contain major food allergens on Jan. 1 in order to comply with the Food Allergen Labeling & Consumer Protection Act of 2004 (FALCPA)
2022 Korean VC Financings Led By Mid-Stage Bioventures
Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.
New COVID Treatments Face FDA, Commercial Barriers Despite Ongoing Need
Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.